Research peptide stacks: the best UK combinations for 2026.

BPC-157 + TB-500

The most widely cited pairing in the UK research-peptide market. BPC-157 (Body Protection Compound 157) and TB-500 (thymosin beta-4 synthetic fragment) are the reference compounds for two distinct wound-healing and repair pathways, and they are frequently studied together because the processes they affect are parallel and non-redundant.

BPC-157’s mechanism centres on VEGF receptor modulation and GABAergic pathway involvement. In the published literature, BPC-157 accelerates healing in tendon, ligament, muscle, and gut tissue models in rodents via angiogenesis (new blood vessel formation) and upregulation of growth factors at the injury site. The pathways are independent of actin dynamics.

TB-500’s mechanism operates primarily through thymosin beta-4, which sequesters G-actin and promotes cell migration and proliferation. The published literature describes TB-500 as promoting actin polymerisation dynamics, endothelial cell migration, and re-epithelialisation in wound models. The actin-binding mechanism is distinct from the VEGF/GABAergic pathways BPC-157 affects.

The logical combination for research: two non-overlapping repair mechanisms studied in parallel gives a more complete picture of tissue-repair biology than either compound alone. Lab77 supplies both as the Wolverine Stack bundle, both with individual Janoshik COAs.

CJC-1295 (No DAC) + Ipamorelin

The canonical growth hormone axis research combination. CJC-1295 without DAC (also called modified GRF 1-29) is a GHRH analogue: it binds the GHRH receptor at the pituitary and stimulates a GH pulse. Ipamorelin is a selective ghrelin receptor agonist (GHRP-class) that independently stimulates GH release via the ghrelin receptor (GHSR-1a).

Why combine them? The two receptors are distinct. A GHRH analogue (CJC-1295) and a ghrelin receptor agonist (Ipamorelin) act on the pituitary through separate signalling pathways, and the published literature shows the combined stimulus produces a GH pulse that is synergistically larger than either compound alone — an effect well-documented in both animal models and human studies.

Ipamorelin is preferred over older GHRPs (GHRP-2, GHRP-6) for this combination because of its high GH-release selectivity with minimal effect on cortisol or prolactin secretion, which is scientifically important when isolating GH pathway effects. Lab77 supplies a pre-formulated CJC-1295/Ipamorelin blend as well as the individual compounds.

GHK-Cu + BPC-157

A skin and connective-tissue focused combination. GHK-Cu (copper peptide, glycyl-L-histidyl-L-lysine:copper(II)) has an extensive published literature in dermatological research models: it stimulates collagen and elastin synthesis, activates antioxidant enzymes, promotes wound contraction, and has been extensively studied in skin-repair and anti-ageing research contexts since Loren Pickart's work in the 1970s-80s.

BPC-157 complements GHK-Cu at a different mechanistic level: where GHK-Cu primarily affects extracellular matrix remodelling and collagen synthesis, BPC-157 contributes angiogenesis (new vessel formation) and growth-factor signalling to the repair process. In full-thickness wound models, vascularisation and matrix remodelling are parallel processes, which is why studying both simultaneously gives a more complete picture.

Storage note: GHK-Cu is light-sensitive due to its copper complex and should always be stored in amber glass under refrigeration. BPC-157 is more stable but follows the same cold-chain practice.

BPC-157 + TB-500 + GHK-Cu

The three-compound regenerative stack extends the Wolverine Stack (BPC-157 + TB-500) by adding GHK-Cu’s collagen and ECM-remodelling mechanism. This combination targets three distinct but complementary repair pathways simultaneously: angiogenesis and growth-factor signalling (BPC-157), actin dynamics and cell migration (TB-500), and extracellular matrix remodelling with collagen synthesis (GHK-Cu).

This combination is particularly common in skin and wound research models where all three processes — vascularisation, cellular migration, and matrix reconstruction — are active and relevant to the research outcome being studied.

NAD+ + Epithalon + MOTS-c

A three-compound combination used in longevity and healthy-ageing research models. Each compound targets a different cellular ageing mechanism.

NAD+ (nicotinamide adenine dinucleotide) is the substrate for sirtuins and PARP enzymes involved in DNA repair and mitochondrial function. NAD+ levels decline with age in most tissues, and supplementation models in preclinical research show effects on mitochondrial biogenesis and metabolic function.

Epithalon (Ala-Glu-Asp-Gly tetrapeptide, also spelled Epitalon) is associated in the published literature with telomerase activation: it has been shown in multiple preclinical and in-vitro studies to activate telomerase and extend telomere length in cell culture models, which is the primary reason it features in longevity research.

MOTS-c is a mitochondria-derived peptide encoded in the mitochondrial 12S rRNA gene. Its published literature centres on AMPK pathway activation, glucose metabolism, and exercise mimetic effects. It represents a distinct mitochondrial signalling axis from NAD+ supplementation.

Selank + Semax

Both Selank and Semax are Russian-origin neuropeptides with published preclinical literature in anxiety, cognition, and neurological research models. They are studied together because they act on different aspects of neurological function.

Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin. Its published literature describes anxiolytic effects in rodent models mediated through the GABA receptor system and effects on tryptophan metabolism. It is one of the few research peptides to have been taken into full clinical development in Russia (registered as a pharmaceutical there).

Semax is a synthetic heptapeptide derived from the ACTH(4-7) sequence. Its literature includes cognitive enhancement, neuroprotection, and BDNF (brain-derived neurotrophic factor) upregulation in rodent models. The mechanism is distinct from Selank’s GABAergic pathway, operating via adrenocorticotropic receptor interactions and BDNF axis.

The combination is studied for complementary neurological effects: anxiolytic activity (Selank) alongside cognitive and neuroprotective activity (Semax), representing two non-overlapping neuropeptide pathways.